Tower Research Capital (TRC)’s Estrella Immunopharma ESLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.41K | Sell |
4,593
-1,053
| -19% | -$1.01K | ﹤0.01% | 4332 |
|
2025
Q1 | $5.23K | Buy |
5,646
+1,858
| +49% | +$1.72K | ﹤0.01% | 4141 |
|
2024
Q4 | $4.55K | Sell |
3,788
-1,940
| -34% | -$2.33K | ﹤0.01% | 4443 |
|
2024
Q3 | $6.64K | Sell |
5,728
-1,423
| -20% | -$1.65K | ﹤0.01% | 4122 |
|
2024
Q2 | $7.51K | Buy |
7,151
+1,580
| +28% | +$1.66K | ﹤0.01% | 4459 |
|
2024
Q1 | $6.91K | Buy |
5,571
+4,939
| +781% | +$6.12K | ﹤0.01% | 4298 |
|
2023
Q4 | $702 | Buy |
+632
| New | +$702 | ﹤0.01% | 5508 |
|